These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21850574)

  • 1. Pressor response to oral tyramine during co-administration with safinamide in healthy volunteers.
    Di Stefano AF; Rusca A
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec; 384(6):505-15. PubMed ID: 21850574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressor response to intravenous tyramine in healthy subjects after safinamide, a novel neuroprotectant with selective, reversible monoamine oxidase B inhibition.
    Cattaneo C; Caccia C; Marzo A; Maj R; Fariello RG
    Clin Neuropharmacol; 2003; 26(4):213-7. PubMed ID: 12897643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of safinamide, a novel drug for Parkinson's disease, on pressor response to oral tyramine: a randomized, double-blind, clinical trial.
    Marquet A; Kupas K; Johne A; Astruc B; Patat A; Krösser S; Kovar A
    Clin Pharmacol Ther; 2012 Oct; 92(4):450-7. PubMed ID: 22948897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressor response to oral tyramine and monoamine oxidase inhibition during treatment with ralfinamide (NW-1029).
    Di Stefano AF; Radicioni MM; Rusca A
    Neurotox Res; 2013 May; 23(4):315-26. PubMed ID: 22872464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity.
    Marzo A; Dal Bo L; Monti NC; Crivelli F; Ismaili S; Caccia C; Cattaneo C; Fariello RG
    Pharmacol Res; 2004 Jul; 50(1):77-85. PubMed ID: 15082032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide.
    Dingemanse J; Hussain Y; Korn A
    Int J Clin Pharmacol Ther; 1996 Apr; 34(4):172-7. PubMed ID: 8861736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
    Weinstock M; Gorodetsky E; Wang RH; Gross A; Weinreb O; Youdim MB
    Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressor response to tyramine after single 24-hour application of a selegiline transdermal system in healthy males.
    Barrett JS; Hochadel TJ; Morales RJ; Rohatagi S; DeWitt KE; Watson SK; Darnow J; Azzaro AJ; DiSanto AR
    J Clin Pharmacol; 1997 Mar; 37(3):238-47. PubMed ID: 9089426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers.
    Audebert C; Blin O; Monjanel-Mouterde S; Auquier P; Pedarriosse AM; Dingemanse J; Durand A; Cano JP
    Eur J Clin Pharmacol; 1992; 43(5):507-12. PubMed ID: 1483487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of MDL 72974A: absence of effect on the pressor response to oral tyramine.
    Hinze C; Kaschube M; Hardenberg J
    J Neural Transm Suppl; 1994; 41():371-5. PubMed ID: 7931253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral linezolid on the pressor response to intravenous tyramine.
    Cantarini MV; Painter CJ; Gilmore EM; Bolger C; Watkins CL; Hughes AM
    Br J Clin Pharmacol; 2004 Nov; 58(5):470-5. PubMed ID: 15521893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine.
    Korn A; Da Prada M; Raffesberg W; Gasic S; Eichler HG
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):17-23. PubMed ID: 2450251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramine.
    Antal EJ; Hendershot PE; Batts DH; Sheu WP; Hopkins NK; Donaldson KM
    J Clin Pharmacol; 2001 May; 41(5):552-62. PubMed ID: 11361052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: A randomized, double-blind, placebo-controlled, phase II/III study.
    Hattori N; Tsuboi Y; Yamamoto A; Sasagawa Y; Nomoto M;
    Parkinsonism Relat Disord; 2020 Jun; 75():17-23. PubMed ID: 32446176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline.
    Schulz R; Antonin KH; Hoffmann E; Jedrychowski M; Nilsson E; Schick C; Bieck PR
    Clin Pharmacol Ther; 1989 Nov; 46(5):528-36. PubMed ID: 2510962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressor effect of oral tyramine during treatment with befloxatone, a new reversible monoamine oxidase-A inhibitor, in healthy subjects.
    Patat A; Berlin I; Durrieu G; Armand P; Fitoussi S; Molinier P; Caille P
    J Clin Pharmacol; 1995 Jun; 35(6):633-43. PubMed ID: 7665725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safinamide: A Review in Parkinson's Disease.
    Blair HA; Dhillon S
    CNS Drugs; 2017 Feb; 31(2):169-176. PubMed ID: 28110399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of Monoamine Oxidase A and B Activity in Long-Term Treated Patients With Parkinson Disease.
    Müller T; Riederer P; Grünblatt E
    Clin Neuropharmacol; 2017; 40(5):208-211. PubMed ID: 28682929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of MAO inhibitors and dietary tyramine: a new experimental model in the conscious rat.
    Fankhauser C; Charieras T; Caille D; Rovei V
    J Pharmacol Toxicol Methods; 1994 Dec; 32(4):219-24. PubMed ID: 7881137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyramine pressor effect in man: studies with moclobemide, a novel, reversible monoamine oxidase inhibitor.
    Korn A; Da Prada M; Raffesberg W; Allen S; Gasic S
    J Neural Transm Suppl; 1988; 26():57-71. PubMed ID: 3162952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.